Fri, November 3, 2017
Thu, November 2, 2017
Wed, November 1, 2017
Tue, October 31, 2017
Mon, October 30, 2017
Fri, October 27, 2017
Thu, October 26, 2017

Edward Tenthoff Initiated (SYRS) at Buy and Held Target at $300 on, Oct 31st, 2017


//stocks-investing.news-articles.net/content/201 .. buy-and-held-target-at-300-on-oct-31st-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Edward Tenthoff of Piper Sandler, Initiated "Syros Pharmaceuticals, Inc." (SYRS) at Buy and Held Target at $300 on, Oct 31st, 2017.

Edward has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward


  • Michael King of "JMP Securities" Upgraded from Hold to Buy on, Thursday, September 28th, 2017

Publication Contributing Sources